161 related articles for article (PubMed ID: 23363467)
21. Modulation of B Cells and Homing Marker on NK Cells Through Extracorporeal Photopheresis in Patients With Steroid-Refractory/Resistant Graft-Vs.-Host Disease Without Hampering Anti-viral/Anti-leukemic Effects.
Wang L; Ni M; Hückelhoven-Krauss A; Sellner L; Hoffmann JM; Neuber B; Luft T; Hegenbart U; Schönland S; Kleist C; Sill M; Chen BA; Wuchter P; Eckstein V; Krüger W; Hilgendorf I; Yerushalmi R; Nagler A; Müller-Tidow C; Ho AD; Dreger P; Schmitt M; Schmitt A
Front Immunol; 2018; 9():2207. PubMed ID: 30349527
[TBL] [Abstract][Full Text] [Related]
22. Extracorporeal photopheresis as a promising strategy for the treatment of graft-versus-host disease after CAR T-cell therapy.
Han H; Wang L; Ding Y; Neuber B; Hückelhoven-Krauss A; Lin M; Yao H; Chen Q; Sauer T; Schubert ML; Guo Z; Müller-Tidow C; Schmitt M; Schmitt A
Blood Adv; 2024 Jun; 8(11):2675-2690. PubMed ID: 38359409
[TBL] [Abstract][Full Text] [Related]
23. Photochemical treatment with S-59 psoralen and ultraviolet A light to control the fate of naive or primed T lymphocytes in vivo after allogeneic bone marrow transplantation.
Truitt RL; Johnson BD; Hanke C; Talib S; Hearst JE
J Immunol; 1999 Nov; 163(9):5145-56. PubMed ID: 10528221
[TBL] [Abstract][Full Text] [Related]
24. Regulatory T-cell suppression of CD8+ T-cell-mediated graft-versus-host reaction requires their presence during priming.
Wang XN; Haniffa MA; Holtick U; Collin MP; Jackson G; Hilkens CM; Holler E; Edinger M; Hoffmann P; Dickinson AM
Transplantation; 2009 Jul; 88(2):188-97. PubMed ID: 19623013
[TBL] [Abstract][Full Text] [Related]
25. Favorable impact of extracorporeal photopheresis in acute and chronic graft versus host disease: Prospective single-center study.
Sakellari I; Gavriilaki E; Batsis I; Mallouri D; Panteliadou AK; Lazaridou A; Vardi A; Constantinou V; Yannaki E; Papalexandri A; Kaloyannidis P; Smias C; Anagnostopoulos A
J Clin Apher; 2018 Dec; 33(6):654-660. PubMed ID: 30394564
[TBL] [Abstract][Full Text] [Related]
26. Mechanisms of action of extracorporeal photochemotherapy.
Heshmati F
Transfus Apher Sci; 2003 Aug; 29(1):61-70. PubMed ID: 12877896
[TBL] [Abstract][Full Text] [Related]
27. Extracorporeal photopheresis affects interleukin (IL)-10 and IL-12 production by monocytes in patients with chronic graft-versus-host disease.
Di Renzo M; Rubegni P; Pasqui AL; Pompella G; De Aloe G; Sbano P; Cuccia A; Castagnini C; Auteri A; Laghi Pasini F; Fimiani M
Br J Dermatol; 2005 Jul; 153(1):59-65. PubMed ID: 16029327
[TBL] [Abstract][Full Text] [Related]
28. Regulatory T cells inhibit CD8(+) T-cell tissue invasion in human skin graft-versus-host reactions.
Mavin E; Ahmed SS; O'Boyle G; Turner B; Douglass S; Norden J; Collin M; Ali S; Dickinson A; Wang XN
Transplantation; 2012 Sep; 94(5):456-64. PubMed ID: 22890131
[TBL] [Abstract][Full Text] [Related]
29. [Immune regulation effect of rat dendritic cells phagocytosing photochemotherapy-treated allogeneic cells on syngeneic T cells].
Zheng DH; Wei YX; Shi BY; Zou YP; DU GS; Zhu ZD; Song JY; Shi YC; Li L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1492-6. PubMed ID: 20030933
[TBL] [Abstract][Full Text] [Related]
30. Extracorporeal Photopheresis in Graft-versus-Host Disease.
Asensi Cantó P; Sanz Caballer J; Solves Alcaína P; de la Rubia Comos J; Gómez Seguí I
Transplant Cell Ther; 2023 Sep; 29(9):556-566. PubMed ID: 37419324
[TBL] [Abstract][Full Text] [Related]
31. Impact of Cryopreservation on Extracorporeal Photopheresis (ECP)-Treated Leukocyte Subsets.
Trunk AD; Radwanski K; Heber C; Taylor A; Hsieh F; Harris A; Lee CJ; Phillips JD; Couriel DR
Transplant Cell Ther; 2023 Jun; 29(6):396.e1-396.e5. PubMed ID: 36828177
[TBL] [Abstract][Full Text] [Related]
32. Modulation and Apoptosis of Neutrophil Granulocytes by Extracorporeal Photopheresis in the Treatment of Chronic Graft-Versus-Host Disease.
Franklin C; Cesko E; Hillen U; Schilling B; Brandau S
PLoS One; 2015; 10(8):e0134518. PubMed ID: 26241482
[TBL] [Abstract][Full Text] [Related]
33. The role of purine analogues in low-intensity regimens with allogeneic hematopoietic stem cell transplantation.
Foss FM
Semin Hematol; 2006 Apr; 43(2 Suppl 2):S35-43. PubMed ID: 16549113
[TBL] [Abstract][Full Text] [Related]
34. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
Talmadge JE
Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
[TBL] [Abstract][Full Text] [Related]
35. Donor lymphocyte infusions combined with systemic PUVA/bexarotene as an effective bimodal immunologic approach in a patient with relapsed cutaneous T cell lymphoma after allogeneic stem cell transplantation.
Schlaak M; Kurschat P; Shimabukuro-Vornhagen A; Scheid C; Chemnitz J; Stadler R; von Bergwelt-Baildon M; Theurich S
Transpl Immunol; 2011 Sep; 25(2-3):163-6. PubMed ID: 21745569
[TBL] [Abstract][Full Text] [Related]
36. Frequent detection of herpes simplex virus antigen in skin and peripheral blood CD34+ mononuclear cells from patients with graft-versus-host disease.
Akpek G; Joseph R; Günay C; Kessler II; Shvartsbeyn M; Bhatnagar B; Aurelian L
Biol Blood Marrow Transplant; 2013 Apr; 19(4):529-37. PubMed ID: 23313704
[TBL] [Abstract][Full Text] [Related]
37. Extracorporeal photopheresis in chronic graft-versus-host disease.
Foss FM; Gorgun G; Miller KB
Bone Marrow Transplant; 2002 May; 29(9):719-25. PubMed ID: 12040467
[TBL] [Abstract][Full Text] [Related]
38. Extracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients.
Weitz M; Strahm B; Meerpohl JJ; Bassler D
Cochrane Database Syst Rev; 2014 Feb; (2):CD009898. PubMed ID: 24569961
[TBL] [Abstract][Full Text] [Related]
39. Extracorporeal photochemotherapy is accompanied by increasing levels of circulating CD4+CD25+GITR+Foxp3+CD62L+ functional regulatory T-cells in patients with graft-versus-host disease.
Biagi E; Di Biaso I; Leoni V; Gaipa G; Rossi V; Bugarin C; Renoldi G; Parma M; Balduzzi A; Perseghin P; Biondi A
Transplantation; 2007 Jul; 84(1):31-9. PubMed ID: 17627234
[TBL] [Abstract][Full Text] [Related]
40. Monoclonal anti-TNF-alpha suppresses graft vs host disease reactions in an in vitro human skin model.
Dickinson AM; Sviland L; Jackson G; Dunn J; Stephens S; Proctor SJ
Cytokine; 1994 Mar; 6(2):141-6. PubMed ID: 8031996
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]